Product Information

DILTIAZEM 120 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.0914 per EA under NDC 50228048401. Its NADAC has been published 192 times since Mar 15, 2023.

FDA first approved this application on Sep 23, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DILTIAZEM 120 MG TABLET

Diltiazem Hydrochloride
$0.0914per EA

Strength

120 mg/1

NDC

50228048401

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

DILTIAZEM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA216521

FDA Approved

9/23/2022

TE Code

AB

On Market Since

9/26/2022

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for DILTIAZEM 120 MG TABLET has been published 192 times since Mar 15, 2023, and over the history we have for it it has declined 69.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0914 per EA
All-time high$0.3137 (Dec 13, 2023)
All-time low$0.0914 (Oct 21, 2026)
52-week high$0.1012
52-week low$0.0914
Median price$0.1754
Average price$0.1813
Largest weekly change+38.6% (Feb 21, 2024)
Weeks tracked192
Tracking sinceMar 15, 2023

Price History

1W

0.0%

1M

-7.7%

3M

-7.7%

6M

-6.6%

1Y

-12.0%

3Y

-61.1%

5Y

N/A

All

-69.6%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DILTIAZEM 120 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 120 MG TABLET, manufactured by ScieGen Pharmaceuticals Inc., is $0.0914 per EA (NDC 50228048401), effective Nov 11, 2026.

How has the price of DILTIAZEM 120 MG TABLET changed over time?

Over the history we have for it, the NADAC for DILTIAZEM 120 MG TABLET has declined 69.6%. It has been tracked across 192 weekly CMS publications since Mar 15, 2023.

What are the highest and lowest recorded NADAC prices for DILTIAZEM 120 MG TABLET?

Since Mar 15, 2023, the NADAC for DILTIAZEM 120 MG TABLET has ranged from a low of $0.0914 (Oct 21, 2026) to a high of $0.3137 (Dec 13, 2023), with a median of $0.1754 per EA.

Are there cheaper alternatives to DILTIAZEM 120 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DILTIAZEM 120 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures DILTIAZEM 120 MG TABLET?

DILTIAZEM 120 MG TABLET (NDC 50228048401) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.